Investigating Drug–Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
CONSPECTUS: This Account highlights recent advances and discusses major challenges in the field of drug-target recognition, binding, and unbinding studied using metadynamics-based approaches, with particular emphasis on their role in structure-based design. Computational chemistry has significantly contributed to drug design and optimization in an extremely broad range of areas, including prediction of target druggability and drug likeness, de novo design, fragment screening, ligand docking, estimation of binding affinity, and modulation of ADMET (absorption, distribution, metabolism, excretion, toxicity) properties. Computationally driven drug discovery must continuously adapt to keep pace with the evolving knowledge of the factors that modulate the pharmacological action of drugs. There is thus an urgent need for novel computational approaches that integrate the vast amount of complex information currently available for small (bio)organic compounds, biologically relevant targets and their complexes, while also accounting accurately for the thermodynamics and kinetics of drug-target association, the intrinsic dynamical behavior of biomolecular systems, and the complexity of protein-protein networks. Understanding the mechanism of drug binding to and unbinding from biological targets is fundamental for optimizing lead compounds and designing novel biologically active ones. One major challenge is the accurate description of the conformational complexity prior to and upon formation of drug-target complexes. Recently, enhanced sampling methods, including metadynamics and related approaches, have been successfully applied to investigate complex mechanisms of drugs binding to flexible targets. Metadynamics is a family of enhanced sampling techniques aimed at enhancing the rare events and reconstructing the underlying free energy landscape as a function of a set of order parameters, usually referred to as collective variables. Studies of drug binding mechanisms have predicted the most probable association and dissociation pathways and the related binding free energy profile. In addition, the availability of an efficient open-source implementation, running on cost-effective GPU (i.e., graphical processor unit) architectures, has considerably decreased the learning curve and the computational costs of the methods, and increased their adoption by the community. Here, we review the recent contributions of metadynamics and other enhanced sampling methods to the field of drug-target recognition and binding. We discuss how metadynamics has been used to search for transition states, to predict binding and unbinding paths, to treat conformational flexibility, and to compute free energy profiles. We highlight the importance of such predictions in drug discovery. Major challenges in the field and possible solutions will finally be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method
Kumar, S., Rosenberg, J. M., Bouzida, D., Swendsen, R. H., & Kollman, P. A. (1992) · Journal of Computational Chemistry · doi:10.1002/jcc.540130812 · Cited by 6,808
Laio, A., & Parrinello, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202427399 · Cited by 5,626
T RANSITION P ATH S AMPLING : Throwing Ropes Over Rough Mountain Passes, in the Dark
Bolhuis, P. G., Chandler, D., Dellago, C., & Geissler, P. L. (2002) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.53.082301.113146 · Cited by 1,972
Atomic-level characterization of the structural dynamics of proteins
Shaw, D. E., Maragakis, P., Lindorff-Larsen, K., Piana, S., Dror, R. O., Eastwood, M. P., Bank, J. A., Jumper, J. M., Salmon, J. K., Shan, Y., et al. (2010) · Science · doi:10.1126/science.1187409 · Cited by 1,923
Drug-target residence time and its implications for lead optimization
Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2082 · Cited by 1,464
Csermely, P., Palotai, R., & Nussinov, R. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.009 · Cited by 821
Markov state models of biomolecular conformational dynamics
Chodera, J. D., & Noé, F. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.04.002 · Cited by 776
Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations
Buch, I., Giorgino, T., & De Fabritiis, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103547108 · Cited by 655
How Does a Drug Molecule Find Its Target Binding Site?
Shan, Y., Kim, E. T., Eastwood, M. P., Dror, R. O., Seeliger, M. A., & Shaw, D. E. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202726y · Cited by 614
Tiwary, P., & Parrinello, M. (2013) · Physical Review Letters · doi:10.1103/physrevlett.111.230602 · Cited by 494
Research works printed but not linked: 53
- Macarron R., 2006, Drug Discovery Today, 11, 277, 10.1016/j.drudis.2006.02.001 · DOI · Paper page
- McCammon J. A., 1998, Curr. Opin. Struct. Biol., 8, 245, 10.1016/S0959-440X(98)80046-8 · DOI
- Shaw D. E., 2008, Commun. ACM, 51, 91, 10.1145/1364782.1364802 · DOI · Paper page
- Harvey M. J., 2009, J. Chem. Theory Comput., 5, 1632, 10.1021/ct9000685 · DOI · Paper page
- Pronk S., 2013, Bioinformatics, 29, 845, 10.1093/bioinformatics/btt055 · DOI · Paper page
- Stone J. E., 2007, J. Comput. Chem., 28, 2618, 10.1002/jcc.20829 · DOI · Paper page
- Mitsutake A., 2013, Methods Mol. Biol., 924, 153, 10.1007/978-1-62703-017-5_7 · DOI
- Patey G. N., 1975, J. Chem. Phys., 63, 2334, 10.1063/1.431685 · DOI · Paper page
- Sugita Y., 1999, Chem. Phys. Lett., 314, 141, 10.1016/S0009-2614(99)01123-9 · DOI · Paper page
- Isralewitz B., 2001, Curr. Opin. Struct. Biol., 11, 224, 10.1016/S0959-440X(00)00194-9 · DOI · Paper page
- Hamelberg D., 2004, J. Chem. Phys., 120, 11919, 10.1063/1.1755656 · DOI · Paper page
- Faradjian A. K., 2004, J. Chem. Phys., 120, 10880, 10.1063/1.1738640 · DOI · Paper page
- Barducci A., 2008, Phys. Rev. Lett., 100, 020603, 10.1103/PhysRevLett.100.020603 · DOI · Paper page
- Grubmüller H., 1995, Phys. Rev. E, 52, 2893, 10.1103/PhysRevE.52.2893 · DOI · Paper page
- Marsili S., 2006, J. Phys. Chem. B, 110, 14011, 10.1021/jp062755j · DOI · Paper page
- Huber T., 1994, J. Comput.-Aided Mol. Des., 8, 695, 10.1007/BF00124016 · DOI · Paper page
- Cvijovicacute D., 1995, Science, 267, 664, 10.1126/science.267.5198.664 · DOI · Paper page
- Darve E., 2008, J. Chem. Phys., 128, 144120, 10.1063/1.2829861 · DOI · Paper page
- Wojtas-Niziurski W., 2013, J. Chem. Theory Comput., 9, 1885, 10.1021/ct300978b · DOI
- Dama J. F., 2014, Phys. Rev. Lett., 112, 240602, 10.1103/PhysRevLett.112.240602 · DOI · Paper page
- Tribello G. A., 2014, Comput. Phys. Commun., 185, 604, 10.1016/j.cpc.2013.09.018 · DOI · Paper page
- Schames J. R., 2004, J. Med. Chem., 47, 1879, 10.1021/jm0341913 · DOI · Paper page
- Klepeis J. L., 2009, Curr. Opin. Struct. Biol., 19, 120, 10.1016/j.sbi.2009.03.004 · DOI · Paper page
- Gervasio F. L., 2005, J. Am. Chem. Soc., 127, 2600, 10.1021/ja0445950 · DOI · Paper page
- Lindorff-Larsen K., 2010, Proteins, 78, 1950, 10.1002/prot.22711 · DOI · Paper page
- Cerutti D. S., 2014, J. Chem. Theory Comput., 10, 4515, 10.1021/ct500643c · DOI
- Shivakumar D., 2012, J. Chem. Theory Comput., 8, 2553, 10.1021/ct300203w · DOI · Paper page
- Masetti M., 2009, J. Phys. Chem. B, 113, 4807, 10.1021/jp803936q · DOI
- Bottegoni G., 2006, J. Chem. Inf. Model., 46, 852, 10.1021/ci050141q · DOI
- Branduardi D., 2005, J. Am. Chem. Soc., 127, 9147, 10.1021/ja0512780 · DOI
- Cavalli A., 2004, J. Med. Chem., 47, 3991, 10.1021/jm040787u · DOI
- Bui J. M., 2003, Biophys. J., 85, 2267, 10.1016/S0006-3495(03)74651-7 · DOI
- Di Leva F. S., 2014, Nucleic Acids Res., 42, 5447, 10.1093/nar/gku247 · DOI
- Vargiu A. V., 2008, Nucleic Acids Res., 36, 5910, 10.1093/nar/gkn561 · DOI
- Colizzi F., 2010, J. Am. Chem. Soc., 132, 7361, 10.1021/ja100259r · DOI · Paper page
- Branduardi D., 2007, J. Chem. Phys., 126, 054103, 10.1063/1.2432340 · DOI · Paper page
- Deng Y., 2009, J. Phys. Chem. B, 113, 2234, 10.1021/jp807701h · DOI · Paper page
- Limongelli V., 2013, Proc. Natl. Acad. Sci. U. S. A., 110, 6358, 10.1073/pnas.1303186110 · DOI · Paper page
- Berteotti A., 2009, J. Am. Chem. Soc., 131, 244, 10.1021/ja806846q · DOI · Paper page
- Sutto L., 2013, Proc. Natl. Acad. Sci. U. S. A., 110, 10616, 10.1073/pnas.1221953110 · DOI · Paper page
- Fidelak J., 2010, J. Phys. Chem. B, 114, 9516, 10.1021/jp911689r · DOI
- Saladino G., 2012, J. Chem. Theory Comput., 8, 1165, 10.1021/ct3001377 · DOI
- Mason J., 2013, In Silico Pharmacol., 1, 23, 10.1186/2193-9616-1-23 · DOI
- Provasi D., 2011, PLoS Comput. Biol., 7, e1002193, 10.1371/journal.pcbi.1002193 · DOI · Paper page
- Bussi G., 2006, J. Am. Chem. Soc., 128, 13435, 10.1021/ja062463w · DOI · Paper page
- Piana S., 2007, J. Phys. Chem. B, 111, 4553, 10.1021/jp067873l · DOI · Paper page
- Söderhjelm P., 2012, Proc. Natl. Acad. Sci. U. S. A., 109, 5170, 10.1073/pnas.1201940109 · DOI
- Limongelli V., 2010, Proc. Natl. Acad. Sci. U. S. A., 107, 5411, 10.1073/pnas.0913377107 · DOI · Paper page
- Grazioso G., 2012, J. Am. Chem. Soc., 134, 453, 10.1021/ja208485w · DOI
- Herbert C., 2013, Cancer Cell, 23, 489, 10.1016/j.ccr.2013.02.018 · DOI
- Pietrucci F., 2009, J. Am. Chem. Soc., 131, 11811, 10.1021/ja903045y · DOI · Paper page
- Juraszek J., 2013, Phys. Rev. Lett., 110, 108106, 10.1103/PhysRevLett.110.108106 · DOI
- Valsson O., 2014, Phys. Rev. Lett., 113, 090601, 10.1103/PhysRevLett.113.090601 · DOI · Paper page
Cited by
Role of Molecular Dynamics and Related Methods in Drug Discovery
De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01684 · Cited by 1,297
Self-citationCournia, Z., Allen, B., & Sherman, W. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00564 · Cited by 789
Enhancing Important Fluctuations: Rare Events and Metadynamics from a Conceptual Viewpoint
Valsson, O., Tiwary, P., & Parrinello, M. (2016) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-040215-112229 · Cited by 647
Molecular dynamics simulations and novel drug discovery
Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1403419 · Cited by 518
Enhanced Sampling Methods for Molecular Dynamics Simulations [Article v1.0]
Hénin, J., Lelièvre, T., Shirts, M. R., Valsson, O., & Delemotte, L. (2022) · Living Journal of Computational Molecular Science · doi:10.33011/livecoms.4.1.1583 · Cited by 372
Metadata
- Authors
- Cavalli, A., Spitaleri, A., Saladino, G., & Gervasio, F. L.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-12-12
- Volume
- 48
- Issue
- 2
- Pages
- 277-285
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2085829368
- Cited by
- 149
- References
- 10
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Ministero dell'Istruzione, dell'Università e della Ricerca
- University College London
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Investigating Drug–Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms. https://app.cochat.ai/papers/10.1021/ar500356n
- The paper
- Cavalli, A., Spitaleri, A., Saladino, G., & Gervasio, F. L. (2015). Investigating Drug–Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms. Accounts of Chemical Research. https://doi.org/10.1021/ar500356n
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.